(
A and
B) Dose-response curves for MβCD:cholesterol in Smo
-/- cells stably expressing WT SMO (solid black circles) or the indicated SMO mutants. D477R (
A) is an activating mutation in the 7TMD, Y134F (
A) is a mutation in the CRD (see
Figure 5) that abrogates cholesterol and oxysterol responses, and ΔCRD (
B) is an activating N-terminal truncation mutant that lacks the entire CRD. (
C)
Gli1 induction in Smo
-/- cells expressing SMO-WT or SMO-G115F (see
Figure 4 and associated discussion) treated with the indicated side-chain oxysterols, each applied at 5 μM as an inclusion complex with 44 μM MβCD. The activity of MβCD:cholesterol (1.2 mM) in both cell lines is shown in (
D) for comparison. (
E) Structures of the various side-chain oxysterols used in
C, with differences from cholesterol highlighted in red.